1 patent currently held
21 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2028. from the record
Of the 21 now held by other companies, 21 name Biossil Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Nov 2028
Next term end
1
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Oct 2027 · High confidence
Cited by 8 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
now held by Biossil Inc.
Also notable
Ends Aug 2036 · High confidence
Cited by 14 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
now held by Biossil Inc.
Also notable
Ends Sep 2032 · High confidence
Cited by 5 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
now held by Biossil Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 16, 2027The maintenance fee for Super-Oxide Dismutase Mimetics (US 10,350,193) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Super-Oxide Dismutase Mimetics | 1 in force | to Nov 2028 |
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,350,193 | Super-Oxide Dismutase Mimetics In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 21 patents in force now held by others · 8 patents ended · 10 applications pending · 8 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.